Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
October 10, 2014
Clinical integration of next generation sequencing: coverage and reimbursement challenges
Patricia A Deverka, Jennifer C Dreyfus
Clinical Chemistry
|
October 3, 2014
Comparative effectiveness research and demonstrating clinical utility for molecular diagnostic tests
Patricia A Deverka, Susanne B Haga
JAMA
|
November 12, 2014
Overcoming the reimbursement barriers for clinical sequencing
Patricia A Deverka, David Kaufman, Amy L McGuire
Annual Review of Pharmacology and Toxicology
|
January 9, 2010
Economic opportunities and challenges for pharmacogenomics
Patricia A Deverka, John Vernon, Howard L McLeod
JAMA
|
September 30, 2024
Payer Coverage Considerations for Alzheimer Disease Blood-Based Biomarker Tests
Patricia A Deverka, Grace A Lin, Kathryn A Phillips
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 12, 2020
Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions
Patricia A Deverka, Michael P Douglas, Kathryn A Phillips
Health Affairs (Project Hope)
|
March 7, 2022
Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access
Patricia A Deverka, Michael P Douglas, Kathryn A Phillips
Journal of Comparative Effectiveness Research
|
November 19, 2013
Stakeholder engagement in comparative effectiveness research: how will we measure success?
Danielle C Lavallee, Carla J Williams, Ellen S Tambor, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
March 1, 2023
A review of economic issues for gene-targeted therapies: Value, affordability, and access
Louis P Garrison, Andrew W Lo, Richard S Finkel, et al.
Health Affairs (Project Hope)
|
May 8, 2018
Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?
Kathryn A Phillips, Patricia A Deverka, Gillian W Hooker, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics
|
October 10, 2014
Clinical integration of next generation sequencing: coverage and reimbursement challenges
Patricia A Deverka, Jennifer C Dreyfus
Clinical Chemistry
|
October 3, 2014
Comparative effectiveness research and demonstrating clinical utility for molecular diagnostic tests
Patricia A Deverka, Susanne B Haga
JAMA
|
November 12, 2014
Overcoming the reimbursement barriers for clinical sequencing
Patricia A Deverka, David Kaufman, Amy L McGuire
Annual Review of Pharmacology and Toxicology
|
January 9, 2010
Economic opportunities and challenges for pharmacogenomics
Patricia A Deverka, John Vernon, Howard L McLeod
JAMA
|
September 30, 2024
Payer Coverage Considerations for Alzheimer Disease Blood-Based Biomarker Tests
Patricia A Deverka, Grace A Lin, Kathryn A Phillips
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 12, 2020
Use of Real-World Evidence in US Payer Coverage Decision-Making for Next-Generation Sequencing-Based Tests: Challenges, Opportunities, and Potential Solutions
Patricia A Deverka, Michael P Douglas, Kathryn A Phillips
Health Affairs (Project Hope)
|
March 7, 2022
Multicancer Screening Tests: Anticipating And Addressing Considerations For Payer Coverage And Patient Access
Patricia A Deverka, Michael P Douglas, Kathryn A Phillips
Journal of Comparative Effectiveness Research
|
November 19, 2013
Stakeholder engagement in comparative effectiveness research: how will we measure success?
Danielle C Lavallee, Carla J Williams, Ellen S Tambor, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
March 1, 2023
A review of economic issues for gene-targeted therapies: Value, affordability, and access
Louis P Garrison, Andrew W Lo, Richard S Finkel, et al.
Health Affairs (Project Hope)
|
May 8, 2018
Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?
Kathryn A Phillips, Patricia A Deverka, Gillian W Hooker, et al.
Page
of 5